Last reviewed · How we verify
Vehicle (SD-101 0%)
Vehicle serves as a control in clinical trials.
At a glance
| Generic name | Vehicle (SD-101 0%) |
|---|---|
| Also known as | Placebo Comparator, SD-101-0.0 |
| Sponsor | Scioderm, Inc. |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
In clinical trials, a vehicle is used as a control to compare the effects of a treatment. It typically contains the same excipients as the treatment but without the active ingredient.
Approved indications
Common side effects
Key clinical trials
- Efficacy and Safety Study to Evaluate SD-101 in Epidermolysis Bullosa (PHASE3)
- Study of Effectiveness and Safety of SD-101 in Participants With Epidermolysis Bullosa (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vehicle (SD-101 0%) CI brief — competitive landscape report
- Vehicle (SD-101 0%) updates RSS · CI watch RSS
- Scioderm, Inc. portfolio CI